Selective low-dose valganciclovir for prevention of cytomegalovirus disease following kidney transplantation.

Objectives: To assess the safety of a cytomegalovirus prophylaxis regimen using selective low-dose valganciclovir.

Methods: Retrospective before-after comparison, including consecutive kidney transplant recipients between 2002 and 2004. Excluded were deaths or graft loss within one month after transplantation.